I
7.95
0.21 (2.71%)
| Previous Close | 7.74 |
| Open | 7.69 |
| Volume | 286,140 |
| Avg. Volume (3M) | 343,185 |
| Market Cap | 1,078,810,752 |
| Price / Earnings (TTM) | 159.00 |
| Price / Sales | 1.18 |
| Price / Book | 4.20 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2026 |
| Profit Margin | -3.76% |
| Operating Margin (TTM) | -4.66% |
| Diluted EPS (TTM) | -0.240 |
| Quarterly Revenue Growth (YOY) | 13.00% |
| Total Debt/Equity (MRQ) | 39.37% |
| Current Ratio (MRQ) | 0.780 |
| Operating Cash Flow (TTM) | 25.74 M |
| Levered Free Cash Flow (TTM) | 24.38 M |
| Return on Assets (TTM) | -2.82% |
| Return on Equity (TTM) | -11.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Bullish |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | InnovAge Holding Corp. | Bullish | Bullish |
AIStockmoo Score
-2.3
| Analyst Consensus | -1.5 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -2.25 |
|
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 85.30% |
| % Held by Institutions | 12.03% |
| 52 Weeks Range | ||
| Median | 7.00 (-11.95%) | |
| Total | 1 Sell | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 23 Feb 2026 | 7.00 (-11.95%) | Sell | 8.92 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Feb 2026 | Announcement | Proven Senior Care Model Takes Center Stage at the Capitol |
| 03 Feb 2026 | Announcement | InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |